Versiti’s Banu Santebennur explains how clean data, semantic layers, and cautious tech adoption prepare clinical research for AI.
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
- The Integration Dilemma: Who Decides Which Tech Stack Wins?
- Why Clinical Trial Sites Are Drowning In Tech Chaos
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Revolutionizing Trial Supply Management With The Power Of Free Picking
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
FDA Pushes For Patient Voice: ePRO In Oncology Trials
FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.
-
Customizing EDC Workflows For Specialty Pharma, Rare Disease Trials
Rare disease and specialty pharma trials demand a level of flexibility with electronic data capture systems that can adapt dynamically without sacrificing data integrity.
-
Innovation And Architecture That Delivers Simplicity And Customizability
Whether you're looking for no-code simplicity, low-code adaptability, or fully programmable control, this purpose-built technology platform supports trials of all complexities with ease.
-
Real-World Data Vs. Real-World Evidence
Unearth the ways real-world data (RWD) and real-world evidence (RWE) in clinical R&D can be used to provide additional validation for new therapies and drugs regarding their efficacy, safety, and value.
-
The False Economy Of Paper Diaries In Clinical Trials
While paper diaries may appear cheaper, but there are hidden costs that make a digital eCOA solution much more affordable in your clinical trial.
-
Medical Device Clinical Trials: Key Considerations For Sponsors And CROs
Medical device trials must align risk class, regulations, and study design. Strong oversight, data, and proactive safety planning support reliable evidence and market approval.
-
6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies
Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.
-
Opportunities For Enhancing Signal Detection In Schizophrenia Trials
Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.
-
The Hidden Cost Of Preferred Vendors
Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.
RECENT NEWSLETTERS
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution
- 06.25.26 -- How AI, Data, And Workflows Are Fixing Trial Execution
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials